135 related articles for article (PubMed ID: 15936756)
1. Stimulation of cell surface plasminogen activation by membrane-bound melanotransferrin: a key phenomenon for cell invasion.
Michaud-Levesque J; Demeule M; Béliveau R
Exp Cell Res; 2005 Aug; 308(2):479-90. PubMed ID: 15936756
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of melanoma brain metastasis by targeting melanotransferrin at the cell surface.
Rolland Y; Demeule M; Fenart L; Béliveau R
Pigment Cell Melanoma Res; 2009 Feb; 22(1):86-98. PubMed ID: 19017294
[TBL] [Abstract][Full Text] [Related]
3. Melanotransferrin induces human melanoma SK-Mel-28 cell invasion in vivo.
Bertrand Y; Demeule M; Michaud-Levesque J; Béliveau R
Biochem Biophys Res Commun; 2007 Feb; 353(2):418-23. PubMed ID: 17196552
[TBL] [Abstract][Full Text] [Related]
4. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
5. Regulation of plasminogen activation: a role for melanotransferrin (p97) in cell migration.
Demeule M; Bertrand Y; Michaud-Levesque J; Jodoin J; Rolland Y; Gabathuler R; Béliveau R
Blood; 2003 Sep; 102(5):1723-31. PubMed ID: 12750156
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
7. Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.
Pass J; Jögi A; Lund IK; Rønø B; Rasch MG; Gårdsvoll H; Lund LR; Ploug M; Rømer J; Danø K; Høyer-Hansen G
Thromb Haemost; 2007 Jun; 97(6):1013-22. PubMed ID: 17549305
[TBL] [Abstract][Full Text] [Related]
8. Plasminogen-dependent internalization of soluble melanotransferrin involves the low-density lipoprotein receptor-related protein and annexin II.
Michaud-Levesque J; Demeule M; Béliveau R
Biol Chem; 2007 Jul; 388(7):747-54. PubMed ID: 17570828
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of endothelial cell movement and tubulogenesis by human recombinant soluble melanotransferrin: involvement of the u-PAR/LRP plasminolytic system.
Michaud-Levesque J; Rolland Y; Demeule M; Bertrand Y; Béliveau R
Biochim Biophys Acta; 2005 Apr; 1743(3):243-53. PubMed ID: 15843038
[TBL] [Abstract][Full Text] [Related]
10. The migration of human smooth muscle cells in vitro is mediated by plasminogen activation and can be inhibited by alpha2-macroglobulin receptor associated protein.
Wijnberg MJ; Quax PH; Nieuwenbroek NM; Verheijen JH
Thromb Haemost; 1997 Aug; 78(2):880-6. PubMed ID: 9268189
[TBL] [Abstract][Full Text] [Related]
11. In vivo inhibition of angiogenesis by a soluble form of melanotransferrin.
Michaud-Levesque J; Demeule M; Béliveau R
Carcinogenesis; 2007 Feb; 28(2):280-8. PubMed ID: 16857721
[TBL] [Abstract][Full Text] [Related]
12. Deletion of the GPI pre-anchor sequence in human p97--a general approach for generating the soluble form of GPI-linked proteins.
Yang J; Tiong J; Kennard M; Jefferies WA
Protein Expr Purif; 2004 Mar; 34(1):28-48. PubMed ID: 14766298
[TBL] [Abstract][Full Text] [Related]
13. Identification of distinct changes in gene expression after modulation of melanoma tumor antigen p97 (melanotransferrin) in multiple models in vitro and in vivo.
Suryo Rahmanto Y; Dunn LL; Richardson DR
Carcinogenesis; 2007 Oct; 28(10):2172-83. PubMed ID: 17449903
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.
Stillfried GE; Saunders DN; Ranson M
Breast Cancer Res; 2007; 9(1):R14. PubMed ID: 17257442
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase.
López-Alemany R; Longstaff C; Hawley S; Mirshahi M; Fábregas P; Jardí M; Merton E; Miles LA; Félez J
Am J Hematol; 2003 Apr; 72(4):234-42. PubMed ID: 12666133
[TBL] [Abstract][Full Text] [Related]
16. EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor.
Henic E; Sixt M; Hansson S; Høyer-Hansen G; Casslén B
Gynecol Oncol; 2006 Apr; 101(1):28-39. PubMed ID: 16263158
[TBL] [Abstract][Full Text] [Related]
17. Characterization of low-glycosylated forms of soluble human urokinase receptor expressed in Drosophila Schneider 2 cells after deletion of glycosylation-sites.
Gårdsvoll H; Werner F; Søndergaard L; Danø K; Ploug M
Protein Expr Purif; 2004 Apr; 34(2):284-95. PubMed ID: 15003263
[TBL] [Abstract][Full Text] [Related]
18. Extracellular matrix metalloproteinase inducer up-regulates the urokinase-type plasminogen activator system promoting tumor cell invasion.
Quemener C; Gabison EE; Naïmi B; Lescaille G; Bougatef F; Podgorniak MP; Labarchède G; Lebbé C; Calvo F; Menashi S; Mourah S
Cancer Res; 2007 Jan; 67(1):9-15. PubMed ID: 17210677
[TBL] [Abstract][Full Text] [Related]
19. The melanoma tumor antigen, melanotransferrin (p97): a 25-year hallmark--from iron metabolism to tumorigenesis.
Suryo Rahmanto Y; Dunn LL; Richardson DR
Oncogene; 2007 Sep; 26(42):6113-24. PubMed ID: 17452986
[TBL] [Abstract][Full Text] [Related]
20. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
